Back to Search
RODNEY LOOK, M.D.
M.D.
Emergency Medical Services (Emergency Medicine) Physician
NPI: 1831120781IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medical Services (Emergency Medicine) PhysicianPrimary
Emergency Medicine — Emergency Medical Services
Code: 207PE0004X
A90710(CA)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
OTHER
Class of 2001
Research & Publications (19)
Initial test of emergency procedure performance in temporary negative pressure isolation by using simulation technologies.
PMID 17719690·Ann Emerg Med·2008
8-other
The effect of tamoxifen or exemestane on bone mineral density during the first 2 years of adjuvant treatment of postmenopausal women with early breast cancer.
PMID 19073509·Clin Breast Cancer·2008
4-observational
Next-generation spirobenzazepines: identification of RWJ-676070 as a balanced vasopressin V1a/V2 receptor antagonist for human clinical studies.
PMID 17942308·Bioorg Med Chem Lett·2007
4-observational
Characterization of RWJ-351647, a novel nonpeptide vasopressin V2 receptor antagonist.
PMID 16620295·Clin Exp Pharmacol Physiol·2006
7-preclinical
Synthesis and evaluation of 3-anilino-quinoxalinones as glycogen phosphorylase inhibitors.
PMID 16143521·Bioorg Med Chem Lett·2005
7-preclinical
Risk counseling and management in patients with lobular carcinoma in situ.
PMID 15862506·Am J Surg·2005
8-other
Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials.
PMID 15603861·Lung Cancer·2005
3-trial
Synthesis and evaluation of spirobenzazepines as potent vasopressin receptor antagonists.
PMID 15125974·Bioorg Med Chem Lett·2004
8-other
3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3.
PMID 15149684·Bioorg Med Chem Lett·2004
8-other
Synthesis and evaluation of nonpeptide substituted spirobenzazepines as potent vasopressin antagonists.
PMID 15149662·Bioorg Med Chem Lett·2004
7-preclinical
Potent nonpeptide vasopressin receptor antagonists based on oxazino- and thiazinobenzodiazepine templates.
PMID 15125926·Bioorg Med Chem Lett·2004
7-preclinical
Synthesis and biological evaluation of novel macrocyclic bis-7-azaindolylmaleimides as potent and highly selective glycogen synthase kinase-3 beta (GSK-3 beta) inhibitors.
PMID 14980636·Bioorg Med Chem·2004
8-other
2,5-disubstituted 3,4-dihydro-2H-benzo[b][1,4]thiazepines as potent and selective V2 arginine vasopressin receptor antagonists.
PMID 14592501·Bioorg Med Chem Lett·2003
7-preclinical
Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors.
PMID 12954055·J Med Chem·2003
7-preclinical
Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3.
PMID 12941331·Bioorg Med Chem Lett·2003
8-other
Synthesis and biological evaluation of novel indoloazepine derivatives as non-peptide vasopressin V2 receptor antagonists.
PMID 12639574·Bioorg Med Chem Lett·2003
8-other
Bridged bicyclic vasopressin receptor antagonists with V(2)-selective or dual V(1a)/V(2) activity.
PMID 12372506·Bioorg Med Chem Lett·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 400 N MCDOWELL BLVD
PETALUMA, CA 94954 - Phone
- (707) 778-1111
Quick Facts
- NPI
- 1831120781
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 25
- Publications
- 19
Are you this provider?
Claim Your Profile